This study aimed to review the availability of sugar-free medicine available in the market using the online Monthly Index of Medical Specialties (MIMS) Malaysia 2016. Data collection was obtained from product information (PI) for prescription medications contained in the MIMS Malaysia 2016. Concise information for each product was collected based on therapeutic class groupings. The therapeutic class obtained from PI was assigned to one of the 11 major therapeutic classes. PI that stated its use in paediatrics was further reviewed for the availability of sugar free ingredient. Each product was then allocated into the poison groups: Group B, Group C and Non-Scheduled Poison. A total of 282 PI items from 336 companies in MIMS Malaysia 2016 that satisfied our eligibility criteria were reviewed. Of the 282 PI items reviewed, most of the products, 169 (59.9%) were sugarbased product, while 87 (30.9%) of them belong to sugar free products. Our study found that most of the medicines reviewed in the MIMS Malaysia 2016 were under Group C (134 of total 282). There is still a high number of sugar-containing medicines despite the promotion of sugar-free medication. Therefore, consumers need to be educated on the use of sugar-free medicines in children to increase the demand and availability in the market.